Literature DB >> 12169632

MLL-ENL cooperates with SCF to transform primary avian multipotent cells.

Cathleen E Schulte1, Marieke von Lindern, Peter Steinlein, Hartmut Beug, Leanne M Wiedemann.   

Abstract

The MLL gene is targeted by chromosomal translocations, which give rise to heterologous MLL fusion proteins and are associated with distinct types of acute lymphoid and myeloid leukaemia. To determine how MLL fusion proteins alter the proliferation and/or differentiation of primary haematopoietic progenitors, we introduced the MLL-AF9 and MLL-ENL fusion proteins into primary chicken bone marrow cells. Both fusion proteins caused the sustained outgrowth of immature haematopoietic cells, which was strictly dependent on stem cell factor (SCF). The renewing cells have a long in vitro lifespan exceeding the Hayflick limit of avian cells. Analysis of clonal cultures identified the renewing cells as immature, multipotent progenitors, expressing erythroid, myeloid, lymphoid and stem cell surface markers. Employing a two-step commitment/differentiation protocol involving the controlled withdrawal of SCF, the MLL-ENL-transformed progenitors could be induced to terminal erythroid or myeloid differentiation. Finally, in cooperation with the weakly leukaemogenic receptor tyrosine kinase v-Sea, the MLL-ENL fusion protein gave rise to multilineage leukaemia in chicks, suggesting that other activated, receptor tyrosine kinases can substitute for ligand-activated c-Kit in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169632      PMCID: PMC125405          DOI: 10.1093/emboj/cdf429

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  C-kit mutations in core binding factor leukemias.

Authors:  A Beghini; P Peterlongo; C B Ripamonti; L Larizza; R Cairoli; E Morra; C Mecucci
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

2.  Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.

Authors:  E Buchdunger; C L Cioffi; N Law; D Stover; S Ohno-Jones; B J Druker; N B Lydon
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

3.  The glucocorticoid receptor is required for stress erythropoiesis.

Authors:  A Bauer; F Tronche; O Wessely; C Kellendonk; H M Reichardt; P Steinlein; G Schütz; H Beug
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

4.  NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases.

Authors:  L Mauvieux; E Delabesse; P Bourquelot; I Radford-Weiss; A Bennaceur; G Flandrin; F Valensi; E A MacIntyre
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

5.  Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

Authors:  Y Yamamoto; H Kiyoi; Y Nakano; R Suzuki; Y Kodera; S Miyawaki; N Asou; K Kuriyama; F Yagasaki; C Shimazaki; H Akiyama; K Saito; M Nishimura; T Motoji; K Shinagawa; A Takeshita; H Saito; R Ueda; R Ohno; T Naoe
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

6.  c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia.

Authors:  M Gari; A Goodeve; G Wilson; P Winship; S Langabeer; D Linch; E Vandenberghe; I Peake; J Reilly
Journal:  Br J Haematol       Date:  1999-06       Impact factor: 6.998

7.  Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.

Authors:  A Danilkovitch-Miagkova; A Miagkov; A Skeel; N Nakaigawa; B Zbar; E J Leonard
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

Review 8.  STI571: targeting BCR-ABL as therapy for CML.

Authors:  M J Mauro; B J Druker
Journal:  Oncologist       Date:  2001

9.  Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.

Authors:  C Wuchter; J Harbott; C Schoch; S Schnittger; A Borkhardt; L Karawajew; R Ratei; V Ruppert; T Haferlach; U Creutzig; B Dörken; W D Ludwig
Journal:  Leukemia       Date:  2000-07       Impact factor: 11.528

10.  Effects of mutant c-kit in early myeloid cells.

Authors:  L K Ashman; P Ferrao; S R Cole; A C Cambareri
Journal:  Leuk Lymphoma       Date:  2000-03
View more
  6 in total

1.  Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.

Authors:  Antonio Cozzio; Emmanuelle Passegué; Paul M Ayton; Holger Karsunky; Michael L Cleary; Irving L Weissman
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

2.  Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.

Authors:  Ryoichi Ono; Hideaki Nakajima; Katsutoshi Ozaki; Hidetoshi Kumagai; Toshiyuki Kawashima; Tomohiko Taki; Toshio Kitamura; Yasuhide Hayashi; Tetsuya Nosaka
Journal:  J Clin Invest       Date:  2005-03-10       Impact factor: 14.808

3.  Translation initiation factor 4E inhibits differentiation of erythroid progenitors.

Authors:  Montserrat Blázquez-Domingo; Godfrey Grech; Marieke von Lindern
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 4.  Molecular pathogenesis of MLL-associated leukemias.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 5.  The role of the MLL gene in infant leukemia.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

6.  Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR.

Authors:  H Dolznig; F Grebien; E M Deiner; K Stangl; A Kolbus; B Habermann; M A Kerenyi; M Kieslinger; R Moriggl; H Beug; E W Müllner
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.